In one paragraphArticle in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Anna Kira VoronovaRadiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0009-0006-9600-0436 Olivia PriorRadiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0009-0000-4913-6716 Athanasios GrigoriouRadiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0003-1826-8040 Francesc SalvàMedical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.ORCID 0000-0001-9240-4907 Elena ElezMedical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.ORCID 0000-0002-4653-6324 Luz M AtlagichRadiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Roser Sala-LlonchDepartment of Biomedicine, Faculty of Medicine, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.ORCID 0000-0003-3576-0475 Marco PalomboCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, UK.ORCID 0000-0003-4892-7967 Els FieremansBernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-1384-8591 Dmitry S NovikovBernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-4213-3050 Raquel Perez-LopezRadiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0002-9176-0130 Francesco GrussuRadiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0002-0945-3909 Funding
Agencia de Gestio d'Ajuts Universitaris i de Recerca 2023PROD00178Agencia de Gestio d'Ajuts Universitaris i de Recerca SGR-Cat2021Agencia Estatal de Investigacion CEX2020-001024-S/AEI/10.13039/501100011033Agencia Estatal de Investigacion PRE2022-102586Cellex FoundationCRIS Cancer Foundation TALENT19-05European Regional Development Fund (European Commission, EU)FERO FoundationFundació Institució dels Centres de Recerca de Catalunya (CERCA)Fundacion BBVA 89/2017Fundacion Cientifica Asociacion Espanola Contra el Cancer PRYCO211023SERRInstituto de Salud Carlos III PI18/01395Instituto de Salud Carlos III PI21/01019'la Caixa' Foundation CaixaResearch Advanced Oncology Research Program'la Caixa' Foundation LCF/BQ/PR22/11920010Prostate Cancer Foundation 18YOUN19UK Research and Innovation MR/T020296/2
6 · The paper itselfAbstract
purposeWe aim to inform the design of new diffusion MRI (dMRI) approaches for microvasculature quantification that enhance the biological specificity of imaging towards cancer.
methodsWe adopted simulation-informed modelling of the vascular dMRI signal. We synthesised signals from 1500 synthetic vascular networks, for a variety of protocols (flow-compensated [FC], non-compensated [NC], hybrid), featuring different
resultsBoth NC and FC synthetic vascular signals exhibited complex behaviour as, for example, non-zero kurtosis and diffusion time dependence. Two independent degrees of freedom appeared recoverable from directionally-averaged vascular signals (SNR of 5). Mean volumetric flow rate
conclusionsSimulation-based modelling of the vascular dMRI signal suggests
Indexed as
Colorectal NeoplasmsDiffusion Magnetic Resonance ImagingImage Processing, Computer-AssistedMicrovesselsNeoplasmsAlgorithmsComputer SimulationHumansImage Interpretation, Computer-AssistedSignal-To-Noise Ratiocancerdiffusion MRImicrovasculaturemodellingsimulations
Identifiers
PMID41794653
PMCPMC13156458
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390